A Study of Cytisinicline for Vaping Cessation in Adult Smokers

NCT05431387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaping
E-Cig Use

Interventions

DRUG: cytisinicline
DRUG: Placebo
BEHAVIORAL: Behavioral support

Sponsor

Achieve Life Sciences